Related Experiment Video
Updated: Jun 8, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
The year in coronary artery disease
Stephan Achenbach1, Christopher M Kramer, William A Zoghbi
1Department of Cardiology, University of Erlangen, Erlangen, Germany. stephan.achenbach@uk-erlangen.de
Insights
Recent advancements in cardiac imaging, including echocardiography, nuclear imaging, cardiac magnetic resonance, and computed tomography, enhance the diagnosis and management of coronary artery disease (CAD). These updates improve detection of stenoses, assessment of myocardial scar, and overall patient prognosis.
Area of Science:
- Cardiology
- Medical Imaging
- Diagnostic Technologies
Background:
- Coronary artery disease (CAD) management relies heavily on imaging for diagnosis and prognosis.
- Key imaging modalities include echocardiography, nuclear imaging, cardiac magnetic resonance (CMR), and computed tomography (CT).
- Continuous technological and protocol advancements refine the accuracy and applicability of these techniques.
Purpose of the Study:
- To review significant developments in cardiac imaging over the past 12 months relevant to CAD.
- To highlight advancements in echocardiography, nuclear imaging, CMR, and CT for CAD assessment.
- To discuss how new technologies and studies impact the diagnostic and prognostic value of cardiac imaging.
Main Methods:
- Review of recent literature and technological advancements in cardiovascular imaging.
- Comparative analysis of echocardiography, nuclear imaging, CMR, and CT in the context of CAD.
- Synthesis of findings from new clinical studies on imaging modalities' diagnostic and prognostic capabilities.
Main Results:
- New technologies, contrast agents, and protocols have expanded the capabilities and accuracy of cardiac imaging for CAD.
- Recent studies provide updated insights into the diagnostic potential, therapeutic implications, and prognostic value of various imaging modalities.
- Understanding the relative strengths and weaknesses of each modality is crucial for selecting optimal imaging strategies.
Conclusions:
- The field of cardiac imaging for coronary artery disease is rapidly evolving with significant recent advancements.
- Echocardiography, nuclear imaging, CMR, and CT continue to be refined, offering improved diagnostic and prognostic information.
- Strategic selection of the most appropriate imaging modality based on clinical scenario and modality-specific performance is essential for effective CAD management.
Abstract:
Imaging plays a central role in the diagnosis and management of coronary artery disease. Imaging is used for the detection of underlying coronary artery stenoses in patients with stable or chronic chest pain, for the assessment of myocardial scar and viability, for assessing prognosis, or for predicting complications. Echocardiography, nuclear imaging, cardiac magnetic resonance, and-more recently-computed tomography are powerful tools to provide answers to these questions. New technology, new contrast agents, and newly developed imaging protocols widen the applicability and increase accuracy of these imaging modalities, and new clinical studies provide information on their diagnostic potential and their therapeutic as well as prognostic value. The relative strengths and weaknesses of the different imaging modalities influence the selection of the most appropriate imaging approach in different clinical scenarios. This article outlines some of the most important developments of the past 12 months in the field of echocardiography, nuclear imaging, cardiac magnetic resonance, and computed tomography as they pertain to coronary artery disease.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
![Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F3777.jpg&w=3840&q=50)